BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37653547)

  • 1. Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension.
    Park S; Ihm SH; Cho IJ; Kim DH; Park JH; Chung WB; Choi S; Lee HY; Kim HC; Sohn IS; Lee EM; Kim JH; Kim KI; Cho EJ; Sung KC; Shin J; Pyun WB
    Clin Hypertens; 2023 Sep; 29(1):25. PubMed ID: 37653547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
    Portaluppi F; Smolensky MH
    Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial.
    Hermida RC; Fernández JR; Mojón A
    Chronobiol Int; 2020 May; 37(5):751-758. PubMed ID: 32683989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature.
    Hermida RC; Mojón A; Fernández JR; Hermida-Ayala RG; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Smolensky MH
    Chronobiol Int; 2023 Jan; 40(1):63-82. PubMed ID: 34190016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
    Stergiou G; Brunström M; MacDonald T; Kyriakoulis KG; Bursztyn M; Khan N; Bakris G; Kollias A; Menti A; Muntner P; Orias M; Poulter N; Shimbo D; Williams B; Adeoye AM; Damasceno A; Korostovtseva L; Li Y; Muxfeldt E; Zhang Y; Mancia G; Kreutz R; Tomaszewski M
    J Hypertens; 2022 Oct; 40(10):1847-1858. PubMed ID: 35983870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
    Hermida RC; Crespo JJ; Domínguez-Sardiña M; Otero A; Moyá A; Ríos MT; Sineiro E; Castiñeira MC; Callejas PA; Pousa L; Salgado JL; Durán C; Sánchez JJ; Fernández JR; Mojón A; Ayala DE;
    Eur Heart J; 2020 Dec; 41(48):4565-4576. PubMed ID: 31641769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotherapy for Hypertension.
    Bowles NP; Thosar SS; Herzig MX; Shea SA
    Curr Hypertens Rep; 2018 Sep; 20(11):97. PubMed ID: 30267334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension.
    Smolensky MH; Hermida RC; Ayala DE; Tiseo R; Portaluppi F
    Blood Press Monit; 2010 Aug; 15(4):173-80. PubMed ID: 20571367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Controversy of Chronotherapy: Emerging Evidence regarding Bedtime Dosing of Antihypertensive Medications in Non-Arteritic Anterior Ischemic Optic Neuropathy.
    Labowsky MT; Rizzo JF
    Semin Ophthalmol; 2023 Jan; 38(1):99-104. PubMed ID: 36625504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension.
    Schillaci G; Battista F; Settimi L; Schillaci L; Pucci G
    Curr Pharm Des; 2015; 21(6):756-72. PubMed ID: 25341857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.
    Hermida RC; Smolensky MH; Balan H; Castriotta RJ; Crespo JJ; Dagan Y; El-Toukhy S; Fernández JR; FitzGerald GA; Fujimura A; Geng YJ; Hermida-Ayala RG; Machado AP; Menna-Barreto L; Mojón A; Otero A; Rudic RD; Schernhammer E; Skarke C; Steen TY; Young ME; Zhao X
    Chronobiol Int; 2021 Jan; 38(1):1-26. PubMed ID: 33342316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting nocturnal hypertension in type 2 diabetes mellitus.
    Rossen NB; Knudsen ST; Fleischer J; Hvas AM; Ebbehøj E; Poulsen PL; Hansen KW
    Hypertension; 2014 Nov; 64(5):1080-7. PubMed ID: 25259747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedtime hypertension chronotherapy: concepts and patient outcomes.
    Smolensky MH; Hermida RC; Ayala DE; Portaluppi F
    Curr Pharm Des; 2015; 21(6):773-90. PubMed ID: 25341856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.